Hussain Maryam R, Ali Faisal S, Larson Scott A, Al Snih Soham
Department of Population Health and Health Disparities, School of Public and Population Health, University of Texas Medical Branch, Galveston, TX 77555, USA.
Department of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Cancers (Basel). 2025 Jun 16;17(12):2003. doi: 10.3390/cancers17122003.
The landscape for the screening of colorectal cancer (CRC) has witnessed multiple triumphs over the past decades from policy-level interventions. In the United States (US), the most prominent intervention of this nature is the Patient Protection and Affordable Care Act (ACA), enacted more than a decade ago. Since its enactment, the ACA has seen multiple legal challenges, and its impact on CRC screening has been relatively well studied. However, a consolidated, concise analysis of the data on this subject is lacking. Herein, we evaluate the impact of the ACA on CRC screening through the lens of a policy analysis, highlighting its strengths and shortcomings, and suggest policy-level interventions to address these shortcomings and improve CRC screening adoption.
在过去几十年里，通过政策层面的干预，结直肠癌（CRC）筛查领域取得了多项成果。在美国，此类最显著的干预措施是十多年前颁布的《患者保护与平价医疗法案》（ACA）。自颁布以来，ACA面临多项法律挑战，其对CRC筛查的影响也得到了较为充分的研究。然而，目前缺乏对该主题数据的综合、简明分析。在此，我们通过政策分析的视角评估ACA对CRC筛查的影响，突出其优点和不足，并提出政策层面的干预措施，以解决这些不足并提高CRC筛查的普及率。
